New heart valve registry aims to improve lives of patients with leaky mitral valves
NCT ID NCT07409285
First seen Feb 15, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This study is a registry that will follow 150 people with severe mitral regurgitation (a leaky heart valve) who receive the HighLife transcatheter mitral valve replacement system. The goal is to see how well the device works and how safe it is in everyday medical practice. Participants will be monitored for technical success, device safety, and reduction of mitral regurgitation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitätsklinikum Ulm
Ulm, Ulm, 89081, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.